Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Richard Shippy, Susan Estabrooks Hahn

Premium

The American Board of Genetic Counseling has appointed Susan Estabrooks Hahn of the University of Miami to be its president-elect.

Hahn is an instructor at the John T. Macdonald Foundation Department of Human Genetics at the Miller School of Medicine. Hahn will serve as president-elect for ABCG in 2013 and as president in 2014.

The ABCG is a credentialing organization that provides certification for the genetic counseling profession in the US and Canada.

Hahn also is assistant director of communications, compliance, and ethics at the Hussman Institute for Human Genomics.


Richard Shippy has joined Illumina as director of global product marketing for clinical genomics within the San Diego firm's diagnostics division. In his new role, Shippy will be responsible for product marketing activities covering clinical genomics with an emphasis on cytogenomics, and will be working with BlueGnome to advance array designs for that market segment. Illumina acquired BlueGnome in September.

Shippy previously worked at Affymetrix for five years, where he held various positions, most recently senior director of strategic product marketing for clinical applications. Prior to joining Affy, Shippy was a senior scientist and computational biologist for GE Healthcare's CodeLink bioarray business.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.